 
        
        
        Geraniin是一种天然的没食子酸单宁,具有抗肿瘤、抗炎和抗高血糖活性,可通过抑制 TNF-α 的释放 (IC50 = 43 μM) 调节炎症反应,常用于癌症和代谢性疾病研究。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | TNF-α ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thalidomide | ✔ | E3 Ligase | 98% | ||||||||||||||||
| GSK2982772 | ++ human RIP1, IC50: 16 nM | 99%+ | |||||||||||||||||
| QNZ | ++++ TNF-α, IC50: 7 nM | NF-κB | 99%+ | ||||||||||||||||
| Lenalidomide | +++ TNF-α, IC50: 13 nM | 99% | |||||||||||||||||
| Pomalidomide | +++ TNF-α, IC50: 13 nM | 98% | |||||||||||||||||
| GSK481 | ✔ | 99%+ | |||||||||||||||||
| Apremilast | ++ TNF-α, IC50: 77 nM | 98% | |||||||||||||||||
| Necrostatin-1 | + RIP1, EC50: 490 nM | 99%+ | |||||||||||||||||
| Acetylcysteine | ✔ | 98% | |||||||||||||||||
| Adalimumab | ✔ | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Geraniin, an active compound isolated from Geranium sibiricum, has been reported to have antioxidant and anti-inflammatory activities. Geraniin protected against CP(cisplatin)-induced nephrotoxicity by inhibiting oxidative stress and inflammatory response[3]. 2.5 µM geraniin significantly inhibited TNF-α-induced BMSCs (bone marrow-derived mesenchymal stem cells) cytotoxicity. 2.5 µM geraniin significantly reduced the expression of RunX2 and Osx miRNA in TNF-α-induced BMSCs. 2.5 µM geraniin suppressed the expression of NF-κB and p38 MAPK protein and promoted the expression of IкB-α protein in the TNF-α-induced BMSCs[4]. Geraniin mitigates LPS-elicited neural/synaptic neurodegeneration, amyloidogenesis, neuroinflammation, and cognitive impairment[5]. Geraniin significantly attenuated LPS-induced pathological changes in the lung. Geraniin also inhibited LPS-induced macrophages and neutrophils infiltration in the lung. Geraniin significantly attenuated LPS-induced elevation of MPO level. LPS-induced TNF-α, IL-6 and IL-1β production were markedly suppressed by treatment of geraniin[6]. Geraniin inhibits LPS-induced THP-1 macrophages switching to M1 phenotype through SOCS1/NF-κB pathway[7]. Geraniin was not toxic to the HFD (high-fat diet) rats but exhibited protection against glucotoxicity and lipotoxicity particularly in the pancreas of the obese rodents[8]. | 
| Concentration | Treated Time | Description | References | |
| PC12 cells | 0.1 μmol/L, 1 μmol/L, 10 μmol/L | 24 hours | To evaluate the protective effect of Geraniin on OGD/R-induced injury in PC12 cells. Results showed that Geraniin significantly increased cell survival rate, decreased oxidative stress markers (LDH, MDA, NO, nNOS), and reduced apoptosis. | Oxid Med Cell Longev. 2022 Feb 18;2022:2152746 | 
| bone marrow-derived mesenchymal stem cells (MSCs) | 1, 5, 10, 20 µM | 24 hours | Geraniin significantly attenuated H2O2-induced cell damage by promoting MSC survival, reducing cellular ROS production and maintaining mitochondrial function. | Int J Mol Med. 2018 Feb;41(2):739-748 | 
| Bone marrow-derived mesenchymal stem cells (BMSCs) | 2.5 µM | 1 day | To study the effect of Geraniin on the expression of RunX2 and Osx miRNA in TNF-α-induced BMSCs. Results showed that 2.5 µM Geraniin significantly upregulated the expression of RunX2 and Osx miRNA. | Stroke Vasc Neurol. 2017 Apr 21;2(2):47-52 | 
| Bone marrow-derived mesenchymal stem cells (BMSCs) | 2.5 µM | 1 day | To study the inhibitory effect of Geraniin on TNF-α-induced cytotoxicity in BMSCs. Results showed that 2.5 µM Geraniin significantly inhibited TNF-α-induced cytotoxicity in BMSCs. | Stroke Vasc Neurol. 2017 Apr 21;2(2):47-52 | 
| PBMCs | 3.125–100 µg/mL | 4 days | Evaluate the inhibitory effect of Geraniin on lymphocyte proliferation, IC50 value of 22.60 µM. | Drug Des Devel Ther. 2016 Jun 9;10:1935-45 | 
| RAW 264.7 cells | 3.125–100 µg/mL | 24 hours | Evaluate the inhibitory effect of Geraniin on NO production, IC50 value of 7.81 µM. | Drug Des Devel Ther. 2016 Jun 9;10:1935-45 | 
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley (SD) rats | MCAO/R model | Intraperitoneal injection | 5 mg/kg, 10 mg/kg, 20 mg/kg | Once daily for three days | To evaluate the protective effect of Geraniin on MCAO/R-induced cerebral ischemia/reperfusion injury. Results showed that Geraniin significantly reduced infarct volume, improved neurological scores, alleviated neuronal pathological changes, and suppressed oxidative stress and apoptosis. | Oxid Med Cell Longev. 2022 Feb 18;2022:2152746 | 
| Sprague Dawley rats | High-fat diet-induced metabolic syndrome model | Oral gavage | 5 mg/kg and 50 mg/kg Geraniin, 115 mg/kg GEE | Once daily for four weeks | Evaluate the effects of Geraniin and GEE on metabolic syndrome parameters, showing that 5 mg Geraniin and 115 mg GEE significantly improved glucose intolerance, lipid metabolism, and inflammatory responses | Antioxidants (Basel). 2022 Mar 25;11(4):632 | 
| Sprague-Dawley rats | High-fat diet-induced obese hypertensive model | Oral | 25 mg/kg/day | Once daily for four weeks | To evaluate the effect of Geraniin on hypertensive vascular remodelling. Geraniin significantly ameliorated high-fat diet-induced vascular remodelling, reduced vascular oxidative stress and systemic inflammation, and enlarged the lumen diameter of the thoracic aorta. | Nutrients. 2023 Jun 9;15(12):2696 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.05mL 0.21mL 0.10mL | 5.25mL 1.05mL 0.52mL | 10.50mL 2.10mL 1.05mL | |
| CAS号 | 60976-49-0 | 
| 分子式 | C41H28O27 | 
| 分子量 | 952.64 | 
| SMILES Code | OC1(O)C2C3=C(OC1(O)C(C=C2C(O[C@H]4[C@@H]([C@H](O5)[C@@H](O[C@@H]4COC(C6=C(C7=C8C=C(C(O)=C7O)O)C(O)=C(C(O)=C6)O)=O)OC(C9=CC(O)=C(C(O)=C9)O)=O)OC8=O)=O)=O)C(O)=C(O)C=C3C5=O | 
| MDL No. | MFCD09038731 | 
| 别名 | NSC 359346 | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C | 
| 溶解方案 | DMSO: 105 mg/mL(110.22 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1